Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Please watch the video at Investors.com - Find Top Growth Stocks With The IBD Screen Of The Day IBD's proprietary RS Rating ...

A Relative Strength Rating upgrade for Honeywell International shows improving technical performance. Will it continue?

Bhubaneswar: Smruti Swarup Patra, known by his stage name ‘Nextion’, has emerged as the first runner-up in the ‘Ultimate ...

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Inc. , a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces that its lead clinical ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...